First step toward duchenne treatment: drug safety check in healthy volunteers
Knowledge-focused
Ongoing
This early-stage trial tests the safety and how the body handles a new drug called GRT6019 in 24 healthy men. The drug is being developed for Duchenne muscular dystrophy, but this study only checks for side effects and drug levels in the blood. Participants take the drug for 4 we…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC